Office of the Vice President for Research

Frequency Therapeutics

Frequency Therapeutics logo

Discoveries in stem cell biology- hearing loss

Frequency Therapeutics is a platform technology that is based on discoveries in stem cell biology made at MIT. Their initial focus is on chronic hearing loss, a potential $20B+ US market with no effective therapeutic solution. Other potential applications include gastrointestinal diseases, ocular, and diabetes.


Will McLean, Co-Founder & CSO